179 / 1578
/
When is SBRT appropriate for patients with
T1-2, N0 NSCLC who are medically operable?
Statement
Consensus
Any patient should be evaluated by a thoracic surgeon, preferably
in a multidisciplinary setting.
100%
For patients with “standard operative risk” (ie, with anticipated
operative mortality of <1.5%) and stage I NSCLC, SBRT is not
recommended as an alternative to surgery outside of a clinical trial.
Discussions about SBRT are appropriate, with the disclosure that
long-term outcomes with SBRT N3 years are not well established.
94%
For patients with “high operative risk” (ie, those who cannot tolerate
lobectomy, but are candidates for sublobar resection) stage I
NSCLC, discussions about SBRT as a potential alternative to
surgery are encouraged.
94%
07.09.17
ESTRO SBRT COURSE 2017
27
/
When is SBRT appropriate for medically
inoperable patients with T1-2, N0 NSCLC
Statement
Consensus
Central location:
Ø
Unique and significant risk
Ø
3-fraction regimens should be avoided
Ø
4-5 fractions recommended
Ø
Adherence to DVH constraints
94%
> 5cm diameter:
Ø
SBRT appropriate option
89%
Lack of tissue confirmation:
Ø
Obtaing tissue confirmation highly recommended
Ø
SBRT possible if biopsy impossible
100%
07.09.17
ESTRO SBRT COURSE 2017
28